Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide

被引:40
作者
Kawabata, A
Kuroda, R
Nishikawa, H
Asai, T
Kataoka, K
Taneda, M
机构
[1] Fac Pharmaceut Sci, Dept Pathophysiol & Therapeut, Higashiosaka, Osaka 5778502, Japan
[2] Fuso Pharmaceut Ind Ltd, Ctr Res & Dev, Osaka 5360025, Japan
[3] Kinki Univ, Fac Med, Dept Neurosurg, Osaka 5898511, Japan
关键词
protease-activated receptor (PAR); protease; thrombin; nitric oxide; nitric oxide synthase; vascular permeability; inflammation; oedema; mast cell degranulation;
D O I
10.1038/sj.bjp.0702513
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 To clarify the role of the first thrombin receptor protease-activated receptor (PAR)-1 in an inflammatory process, we tested and characterized the effect of intraplantar (i.pl.) administration of the highly specific PAR-1 agonist TFLLR-NH2 in rat hindpaw. 2 TFLLR-NH2 administered i.pl. at 0.01-0.03 mu mol per paw enhanced vascular permeability in the hindpaw and produced paw oedema in a dose-dependent manner, This effect was almost completely abolished by repeated pretreatment with compound 48, 80 to deplete inflammatory mediators in mast cells. 3 The NO synthase inhibitor N-G-nitro-L-arginine methyl ester or N-iminoethyl-L-ornithine. preadministered i.pl., stereospecifically potentiated the i.pl. TFLLR-NH2-induced permeability increase, while the NO donor sodium nitroprusside or KOC-18, given i.pl., suppressed the effect of TFLLR-NH2. 4 These findings demonstrate that specific activation of PAR-1 produces increased vascular permeability accompanied by oedema formation in the rat hindpaw. predominantly via mast cell degranulation, and that endogenous and exogenous NO plays a protective role in the PAR-1-mediated inflammatory event.
引用
收藏
页码:1856 / 1862
页数:7
相关论文
共 41 条
[1]   Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[2]   Ligand cross-reactivity within the protease-activated receptor family [J].
Blackhart, BD ;
Emilsson, K ;
Nguyen, D ;
Teng, W ;
Martelli, AJ ;
Nystedt, S ;
Sundelin, J ;
Scarborough, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16466-16471
[3]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[4]   THE INDUCTION OF NITRIC-OXIDE SYNTHASE AND INTESTINAL VASCULAR-PERMEABILITY BY ENDOTOXIN IN THE RAT [J].
BOUGHTONSMITH, NK ;
EVANS, SM ;
LASZLO, F ;
WHITTLE, BJR ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1189-1195
[5]   Thrombin functions as an inflammatory mediator through activation of its receptor [J].
Cirino, G ;
Cicala, C ;
Bucci, MR ;
Sorrentino, L ;
Maraganore, JM ;
Stone, SR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :821-827
[6]  
DIROSA M, 1971, J PATHOL, V104, P12
[7]   NITRIC-OXIDE MODULATES VASCULAR-PERMEABILITY IN THE RAT CORONARY CIRCULATION [J].
FILEP, JG ;
FOLDESFILEP, E ;
SIROIS, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :323-326
[8]   MODULATION BY NITRIC-OXIDE OF PLATELET-ACTIVATING FACTOR-INDUCED ALBUMIN EXTRAVASATION IN THE CONSCIOUS RAT [J].
FILEP, JG ;
FOLDESFILEP, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (04) :1347-1352
[9]   Identification of potential activators of proteinase-activated receptor-2 [J].
Fox, MT ;
Harriott, P ;
Walker, B ;
Stone, SR .
FEBS LETTERS, 1997, 417 (03) :267-269
[10]   ROLE OF EICOSANOIDS BUT NOT NITRIC-OXIDE IN THE PLATELET-ACTIVATING FACTOR-INDUCED INCREASE IN VASCULAR-PERMEABILITY IN MOUSE SKIN [J].
FUJII, E ;
IRIE, K ;
UCHIDA, Y ;
OHBA, K ;
MURAKI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 273 (03) :267-272